Study at a glance
What causes hereditary vitamin D-resistant rickets?
Rare inherited changes can severely damage the vitamin D receptor, the protein that allows cells to respond to active vitamin D. Poor calcium absorption can then lead to rickets, a disorder in which growing bones do not harden properly.
Can this happen even when active vitamin D levels are high?
Yes. The problem can be a faulty response to the hormone rather than a shortage of it. Different gene changes interfere with different receptor functions, so the effects are not identical in every affected person.
Do common differences in the vitamin D receptor gene mean the same thing?
No. The rare gene changes discussed here can cause major loss of receptor function. Common differences in the gene usually raise a different question about smaller differences that vary between cells and studies. They should not be treated as equivalent to this inherited disorder.
Read the full article below ↓Hereditary vitamin D-resistant rickets (HVDRR) provides unusually direct human evidence for what happens when the vitamin D receptor itself loses function. Unlike a common-variant association, these rare disorders connect a pathogenic VDR genotype to a defined molecular defect and then to failure of receptor-mediated responses to 1,25-dihydroxyvitamin D. The evidence is powerful precisely because the mutations can break different parts of the receptor system in different ways.
The disease is receptor resistance, not simply vitamin D deficiency
Feldman and Malloy describe HVDRR as a severe early-onset disorder in which loss-of-function VDR mutations impair vitamin-D signalling. Typical biochemical consequences include hypocalcaemia, secondary hyperparathyroidism and hypophosphataemia with rickets, often despite very high endogenous 1,25-dihydroxyvitamin-D concentrations. That combination is mechanistically important: increasing hormone production cannot restore a receptor pathway that is unable to respond normally.
The dominant physiological defect is impaired intestinal VDR signalling and calcium absorption. Some patients can respond to very high concentrations of vitamin D metabolites when a mutant receptor retains partial function, but mutations that abolish DNA binding, RXR heterodimerisation, receptor production or other essential transcriptional steps can remain highly resistant. Treatment experience therefore reinforces the molecular point that ‘VDR mutation’ is not a single functional category.
Different domains produce different loss-of-function mechanisms
Mutations in the DNA-binding domain can preserve ligand binding while preventing the receptor from engaging DNA. Ligand-binding-domain mutations can instead reduce affinity for 1,25-dihydroxyvitamin D, disturb heterodimerisation with RXR, or impair coactivator recruitment. Nonsense, frameshift and splice-site mutations can truncate the protein or eliminate functional receptor expression. Each lesion interrupts a different step between hormone recognition and transcription.
This domain-level distinction is experimentally useful. A patient can therefore have severe hormone resistance because the receptor cannot bind ligand, because it cannot bind DNA, because it cannot assemble correctly with RXR, because it cannot recruit transcriptional machinery, or because sufficiently intact receptor protein is not produced. The same clinical label can arise from multiple molecular failures.
Five newly analysed patients linked sequence changes to receptor function
Malloy and colleagues analysed five previously unreported HVDRR patients from several countries. All had clinical and radiographic rickets and hypocalcaemia; four with available measurements had elevated circulating 1,25-dihydroxyvitamin D. The investigators sequenced VDR, recreated identified mutations in wild-type VDR cDNA and tested 1,25-dihydroxyvitamin-D3-mediated transactivation in COS-7 cells.
They identified four novel mutations together with two previously described variants. The novel changes included C60W in the DNA-binding domain, D144N and N276Y in the ligand-binding domain, and a two-base deletion affecting the exon-3 splice donor and producing premature termination. C60W, located in the second zinc finger, was completely inactive in transactivation assays and was interpreted as a DNA-binding failure. A frameshift mutation in another patient produced a severely truncated receptor; patient fibroblasts showed no specific radioligand binding and no 24-hydroxylase response to hormone.
The growing mutation catalogue maps receptor architecture onto human disease
At the time of the Malloy patient report, the authors summarised 50 unique VDR mutations, including deletions, splice-site mutations, nonsense changes, an insertion/duplication and numerous missense mutations distributed across the DNA: and ligand-binding domains. Feldman and Malloy’s synthesis similarly shows how this heterogeneous catalogue can be organised by receptor function rather than by variant name alone.
That organisation is more informative than simply counting mutations. Changes at ligand-contact residues such as Arg274 or His305 can lower hormone affinity. DNA-binding-domain mutations can leave ligand binding intact yet abolish DNA response. Other ligand-binding-domain mutations interfere with RXR or coactivators. The human disease therefore functions as a set of natural perturbation experiments across the VDR signalling chain.
Alopecia is informative but belongs to a distinct mechanistic question
Many, but not all, people with HVDRR develop alopecia. The mutation-class pattern is biologically important because it helps separate classical ligand-dependent endocrine signalling from an additional receptor function in hair follicles. However, this page does not use alopecia to redefine the HVDRR phenotype or imply that hair loss is inevitable. The dedicated VDR-Related Alopecia and Unliganded Hair-Follicle Biology synthesis addresses that distinct reader function.
What rare pathogenic mutations can, and cannot, tell us
The causal strength of HVDRR evidence is high for severe receptor dysfunction: pathogenic mutations with demonstrated molecular defects can produce profound resistance to 1,25-dihydroxyvitamin D and the associated mineral phenotype. But the external validity is narrow. These are rare, usually biallelic, high-impact mutations studied in small patient populations; they do not provide effect sizes for common VDR polymorphisms, ordinary variation in receptor abundance, or common multifactorial disease.
That distinction is why the governed comparison with Vitamin D Receptor Polymorphisms matters: rare Mendelian loss of function and common population variation answer different genetic questions.
Primary evidence used in this synthesis
- Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets · BoneKEy Rep. 2014;3:510. DOI: 10.1038/bonekey.2014.5.
- Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets · Mol Genet Metab. 2014. DOI: 10.1016/j.ymgme.2013.10.014.
Related reading
A Novel Compound Nonsense Variant in CYP27B1 Causes an Atypical Form of Vitamin D-Dependent Rickets Type 1A: A Case Report of Two Siblings in a Mexican Family
Written informed consent was obtained from all participants for genetic analysis and publication of the results.
Original paper ↗Read more →A PAI‐1 antagonist ameliorates hypophosphatemia in the Hyp vitamin D‐resistant rickets model mouse
The purpose of this study was to investigate the potential of TM5614 as a therapeutic agent for the treatment of congenital FGF23‐related hypophosphatemic rickets and osteomalacia in humans by administering TM5614 to Hyp mice and examining its curative effect on hypophosphatemia.
Original paper ↗Read more →Characterization of Rickets Type II Model Rats to Reveal Functions of Vitamin D and Vitamin D Receptor
GM rats exhibited markedly elevated plasma parathyroid hormone and 1,25D3 levels compared to those of WT rats.
Original paper ↗Read more →Functional Analysis of VDR Gene Mutation R343H in A Child with Vitamin D-Resistant Rickets with Alopecia
The functional study of different mutations on vitamin D receptor (VDR) gene causing hereditary vitamin D-resistant rickets (HVDRR) remains limited.
Original paper ↗Read more →Genetic analysis combined with 3D‐printing assistant surgery in diagnosis and treatment for an X‐linked hypophosphatemia patient
Hypophosphatemia is mainly characterized by hypophosphatemia and a low level of 1alpha,25‐Dihydroxyvitamin D2 (1,25‐(OH)2D2) and/or 1alpha,25‐Dihydroxyvitamin D3 (1,25‐(OH)2D3) in the blood.
Original paper ↗Read more →Inactivation of a Novel FGF23 Regulator, FAM20C, Leads to Hypophosphatemic Rickets in Mice
In vitro gain: and loss-of-function were examined by adding recombinant FAM20C to MC3T3-E1 cells and by lentiviral shRNA: mediated knockdown of FAM20C in human and mouse osteogenic cell lines.
Original paper ↗Read more →Mutations in the CYP27B1 gene cause vitamin D dependent rickets in pugs
Rickets is a disorder of bone development and can be the result of either dietary or genetic causes.
Original paper ↗Read more →The Diagnosis and Therapy of XLH
PHEX dysfunction results in increased production and secretion of the phosphaturic hormone fibroblast growth factor 23 (FGF23) from bone.
Original paper ↗Read more →The Variant p.Ala84Pro Is Causative of X-Linked Hypophosphatemic Rickets: Possible Relationship with Burosumab Swinging Response in Adults
Loss of function mutations in the PHEX gene could determine X-linked dominant hypophosphatemia.
Original paper ↗Read more →Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: A novel mechanism of dominant inheritance
In this report, we aimed to confirm whether HVDRR is occasionally inherited as a dominant trait.
Original paper ↗Read more →Clinical and genetic findings in a Chinese family with VDR-associated hereditary vitamin D-resistant rickets
A non-consanguineous family of Chinese Han origin with one affected individual demonstrating HVDRR was recruited, with the proband evaluated clinically, biochemically and radiographically.
Original paper ↗Read more →Novel Vitamin D Receptor Mutations in Hereditary Vitamin D Resistant Rickets in Chinese
Hereditary 1, 25-dihydroxyvitamin D-resistant rickets (HVDRR), a rare recessive disease, is caused by mutation in the VDR gene encoding the vitamin D receptor leading to the resistance to vitamin D.
Original paper ↗Read more →VDR-Related Alopecia and Unliganded Hair-Follicle Biology: Evidence Synthesis
Evidence synthesis of VDR mutation classes, alopecia and the evidence for unliganded VDR functions in hair-follicle biology.
Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats
Active vitamin D form 1α,25-dihydroxtvitamin D3 (1,25(OH)2D3) plays pivotal roles in calcium homeostasis and osteogenesis via its transcription regulation effect via binding to vitamin D receptor (VDR).
Original paper ↗Read more →Vitamin D-Resistant Rickets and Cinacalcet: One More Favorable Experience
Hereditary vitamin D-resistant rickets (HVDRR) is an autosomal recessive disorder characterized by early onset of severe rickets, with a complete triad of clinical, biochemical and skeletal abnormalities.
Original paper ↗Read more →Clinical Phenotype in a Toddler with a Novel Heterozygous Mutation of the Vitamin D Receptor
We present the clinical phenotype of a toddler who presented with vitamin D-resistant rickets, with one of the highest initial levels of alkaline phosphatase and parathyroid hormone (PTH) levels reported in the literature.
Original paper ↗Read more →Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector
On the other hand, control-AdV was injected into 7-week-old female rats (control-AdV rats); non-infected Vdr-KO rats (control rats) were also examined.
Original paper ↗Read more →Vitamin D Receptor Polymorphism among Rickets Children in Mongolia
We therefore investigated whether VDR polymorphism is related to high prevalence of rickets in Mongolia and to bone properties in childhood.
Original paper ↗Read more →Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants
The Vitamin D receptor (VDR) plays a key role in calcium homeostasis, as well as in cell proliferation and differentiation.
Original paper ↗Read more →Relationship between vitamin D receptor gene polymorphisms (BsmI, TaqI, ApaI, and FokI) and calcium intake on bone mass in young Japanese women
Therefore, the aim of the present study was to reevaluate the relationship between genetic and dietary factors, as well as its influence on bone mass in young Japanese women, with particular emphasis on vitamin D receptor (VDR) gene polymorphisms and calcium intake.
Original paper ↗Read more →Original sources
Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets
Published in · BoneKEy Rep (2014).
Publication details
Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets · BoneKEy Rep. 2014;3:510. DOI: 10.1038/bonekey.2014.5.
Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets
Published in · Mol Genet Metab (2014).
Publication details
Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets · Mol Genet Metab. 2014. DOI: 10.1016/j.ymgme.2013.10.014.